RBV
Showing 1 - 25 of 495
Botulism Trial in Richmond (rBV A/B)
Not yet recruiting
- Botulism
- rBV A/B
-
Richmond, CaliforniaCalifornia Department of Public Health
Oct 31, 2023
Hepatitis C, Cirrhosis Trial (Sofosbuvir/Velpatasvir + Ribavirin, Sofosbuvir/Velpatasvir/Voxilaprevir)
Not yet recruiting
- Hepatitis C
- Cirrhosis
- Sofosbuvir/Velpatasvir + Ribavirin
- Sofosbuvir/Velpatasvir/Voxilaprevir
- (no location specified)
Jul 20, 2022
Hepatitis C Trial in Denver (Simeprivir (SMV), Sofosbuvir (SOF), Ribavirin (RBV))
Terminated
- Hepatitis C
- Simeprivir (SMV)
- +2 more
-
Denver, ColoradoUniversity of Colorado Denver (Leprino Building)
Aug 16, 2021
Chronic Hepatitis C, Hepatitis C Virus Trial (ABT-493, ABT-530, ribavirin (RBV))
SOF/VEL±RBV: Efficacy and Safety in GT 3 and 6 HCV Patients
Recruiting
- Hepatitis C
- Epclusa (sofosbuvir and velpatasvir)
-
Guangzhou, Guangdong, ChinaDeparment of Infectious Diseases, the Second Affiliated Hospital
Jul 1, 2021
Covid19, SARS-CoV Infection Trial in Johannesburg (Placebo, DuACT)
Completed
- Covid19
- SARS-CoV Infection
- Placebo
- DuACT
-
Johannesburg, Gauteng, South AfricaSunnyside Office Park
Jul 13, 2022
Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))
Completed
- Chronic Hepatitis C Infection
- Compensated Cirrhosis
- ABT-450/r/ABT-267, ABT-333
- Ribavirin (RBV)
- (no location specified)
Jul 8, 2021
Chronic Hepatitis C Virus Infection Trial (OBV/PTV/r, Sofosbuvir, Ribavirin (RBV))
Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))
Completed
- Chronic Hepatitis C Virus (HCV) Infection Genotype 1
- ABT-450/r/ABT-267
- +2 more
-
Phoenix, Arizona
- +47 more
Jun 27, 2022
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +4 more
- (no location specified)
Jul 29, 2021
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +4 more
- (no location specified)
Jul 8, 2021
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for Ribavirin)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +2 more
- (no location specified)
Jul 8, 2021
Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ribavirin)
Completed
- Chronic Hepatitis C Infection
- ABT-450/r/ABT-267, ABT-333
- +2 more
- (no location specified)
Jul 8, 2021
Hepatitis C Virus Trial (ABT-450/r/ABT-267, Ribavirin)
Completed
- Hepatitis C Virus
- (no location specified)
Jul 28, 2021
Chronic Hepatitis C Virus, Hepatitis C Virus Trial (ABT-493/ABT-530, sofosbuvir (SOF), ribavirin (RBV))
Completed
- Chronic Hepatitis C Virus
- Hepatitis C Virus
- ABT-493/ABT-530
- +2 more
- (no location specified)
Jul 14, 2021
Hepatitis C Infection, HIV Infection Trial in Brazil, Puerto Rico, United States (Glecaprevir/Pibrentasvir (G/P), Ribavirin
Recruiting
- Hepatitis C Infection
- HIV Infection
- Glecaprevir/Pibrentasvir (G/P)
- Ribavirin (RBV)
-
San Diego, California
- +15 more
Dec 19, 2022
Chronic Hepatics C Virus (HCV) Genotype 1, Non-Cirrhotic, Cirrhosis Trial in Beijing (TG-2349, DAG181, Ribavirin)
Completed
- Chronic Hepatics C Virus (HCV) Genotype 1
- +3 more
- TG-2349
- +2 more
-
Beijing, ChinaBeijing Tsinghua Changgung Hospital
Feb 2, 2021
HCV Trial in Beijing (Ravidasvir, Danoprevir, Ritonavir)
Completed
- HCV
- Ravidasvir
- +7 more
-
Beijing, Beijing, ChinaPeking University People's hospital
Jul 25, 2020